Anti-Human Osteoprotegerin (Clone 69146)
Anti-Human Osteoprotegerin (Clone 69146) (O129-GRP)
Products
Description
Osteoprotegerin (OPG), also known as osteoclastogenesis inhibitory factor (OCIF) is a cytokine, which can inhibit osteoclast differentiation, activity, and survival.1 It is a member of the tumor necrosis factor (TNF) receptor superfamily.2 OPG may provide a pharmacological tool for osteoporotic and erosive bone disorders.3
Specifications
| Manufacturer | Leinco Technologies Inc |
|---|---|
| Manufacturer Cat# | O129 |
| Formulation | This monoclonal antibody has been 0.2 µm filtered and lyophilized from modified Dulbecco's phosphate buffered saline (1X PBS) pH 7.2 - 7.3 containing 5.0% w/v trehalose with no calcium, magnesium or preservatives present. |
| Alternate Names | Monoclonal Antibody Osteoprotegerin TNFRSF11B Osteoclast Inhibitory Factor (OCIF) MGC29565 TR1 OCIT 69146 OPG Human Anti-Human Osteoprotegerin |
| Isotype | IgG1 |
| Clone | 69146 |
| Target | Osteoprotegerin |
| Antibody Type | Monoclonal |
| Applications | N |
| Storage | -20°C to -70°C |
| Protein | Osteoprotegerin |